237 related articles for article (PubMed ID: 11906757)
1. Distribution of pertussis antibodies among different age groups in Japan.
Konda T; Kamachi K; Iwaki M; Matsunaga Y
Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
3. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
4. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
[TBL] [Abstract][Full Text] [Related]
6. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.
Cattaneo LA; Reed GW; Haase DH; Wills MJ; Edwards KM
J Infect Dis; 1996 May; 173(5):1256-9. PubMed ID: 8627081
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
8. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.
García-Corbeira P; Dal-Ré R; Aguilar L; García-de-Lomas J
Vaccine; 2000 Apr; 18(21):2173-6. PubMed ID: 10717335
[TBL] [Abstract][Full Text] [Related]
10. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
11. Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.
Polyzou A; Pournaras S; Dafni U; Sofianou D; Christeli E; Patrinos S; Tsakris A
J Clin Lab Anal; 2004; 18(3):211-4. PubMed ID: 15103688
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
13. Pertussis seroepidemiology in Taipei.
Chiu TF; Lee CY; Lee PI; Lu CY; Lin HC; Huang LM
J Formos Med Assoc; 2000 Mar; 99(3):224-8. PubMed ID: 10820955
[TBL] [Abstract][Full Text] [Related]
14. The seroepidemiology of B. pertussis infection in Catalonia, Spain.
Domínguez A; Vidal J; Plans P; Salleras L
Epidemiol Infect; 2001 Apr; 126(2):205-10. PubMed ID: 11349970
[TBL] [Abstract][Full Text] [Related]
15. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.
Grimprel E; Bégué P; Anjak I; Njamkepo E; François P; Guiso N
Clin Diagn Lab Immunol; 1996 Jan; 3(1):93-7. PubMed ID: 8770511
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
Hodder SL; Cherry JD; Mortimer EA; Ford AB; Gornbein J; Papp K
Clin Infect Dis; 2000 Jul; 31(1):7-14. PubMed ID: 10913389
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
[TBL] [Abstract][Full Text] [Related]
18. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
19. Japanese clinical trials with Takeda acellular pertussis vaccine.
Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
[TBL] [Abstract][Full Text] [Related]
20. Age-related differences in patterns of increased Bordetella pertussis antibodies.
Prince HE; Lieberman JM; Cherry JD
Clin Vaccine Immunol; 2012 Apr; 19(4):545-50. PubMed ID: 22357646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
